Preliminary research show conolidine may possibly inhibit unique ion channels, lowering neuronal excitability and limiting pain signals. This system is especially pertinent in neuropathic soreness, the place abnormal signaling triggers persistent soreness. Moreover, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integral to s